Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
197.4 USD | +1.29% | +0.33% | -13.40% |
May. 30 | JPMorgan Adjusts Price Target on Laboratory Corp of America Holdings to $243 From $261 | MT |
May. 23 | Some of the biggest splits in Corporate America | RE |
Summary
- Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
- According to Refinitiv, the company's ESG score for its industry is good.
Strengths
- The company's profit outlook over the next few years is a strong asset.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- Analyst opinion has improved significantly over the past four months.
- Considering the small differences between the analysts' various estimates, the group's business visibility is good.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
Weaknesses
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
- The group usually releases earnings worse than estimated.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Healthcare Facilities & Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-13.40% | 16.43B | B | ||
+21.81% | 88.99B | C+ | ||
-23.71% | 74.82B | B- | ||
+1.06% | 26.63B | C+ | ||
+3.88% | 17.88B | A- | ||
+2.67% | 15.77B | A- | ||
+77.00% | 13.21B | C+ | ||
+69.17% | 13.08B | C- | ||
+38.53% | 12.9B | B- | ||
+22.01% | 12.7B | B- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- LH Stock
- Ratings Labcorp Holdings Inc.